跳至主要内容
临床试验/NCT02920489
NCT02920489已完成不适用

Impact of Individualized Timing of Analgesia on the Effectiveness of Labor Analgesia: a Randomized Controlled Trial

Peking University First Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2016年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
The most severe labor pain score during labor

研究概览

简要总结

Neuraxial analgesia is the gold standard to relieve labor pain. A recent "Practice guidelines for obstetric anesthesia" suggests that neuraxial analgesia should be provided in the early stage of labor (cervical dilation < 5 cm) or on a individualized basis. The purpose of this randomized controlled trial is to investigate whether neuraxial labor analgesia administered on an individualized basis can improve analgesia quality and maternal satisfaction.

详细描述

Neuraxial analgesia is the gold standard to relieve labor pain. It also helps to attenuate maternal anxiety and improve maternal satisfaction. A recent "Practice guidelines for obstetric anesthesia" suggests that neuraxial analgesia should be provided in the early stage of labor (cervical dilation < 5 cm) or, for some special patients, be provided on a individualized basis. Studies showed that, when compared with late administration, early administration of labor analgesia resulted in equivocal findings for spontaneous, instrumented, and cesarean delivery. The investigators hypothesize that neuraxial labor analgesia provided on an individualized basis will further improve analgesia quality and maternal satisfaction. The purpose of this randomized controlled trial is to investigate whether neuraxial labor analgesia administered on an individualized basis can improve analgesia quality and maternal satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 36 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Nulliparas (aged 18-36 years) with single cephalic term pregnancy;
  • Plan to deliver vaginally, and are considered suitable for a trial of vaginal delivery by obstetricians;
  • Admitted to the delivery room;
  • Agree to receive epidural analgesia during labor.

排除标准

  • History of psychiatric disease (indicate those that are diagnosed before or during pregnancy by psychiatrists);
  • Presence of contraindications to epidural analgesia, which includes: (1) History of infectious disease of the central nervous system (poliomyelitis, cerebrospinal meningitis, encephalitis, etc.); (2) History of spinal or intra-spinal disease (trauma or surgery of spinal column, intra-spinal canal mass, etc.); (3) Systemic infection (sepsis); (4) Skin or soft tissue infection at the site of epidural puncture; (5) Coagulopathy.
  • Other reasons that are considered unsuitable for study participation.

研究组 & 干预措施

Individualized epidural analgesia

Experimental

Epidural catheterization will be performed after the beginning of the first stage of labor. Epidural analgesia will begin when asked by parturients and the numeric rating scale of pain is 5 or higher. A loading dose (10 ml mixture of 0.1% ropivacaine and 0.5 ug/ml sufentanil) will be administered through the epidural catheter. After a 20-minute observation, a patient-controlled analgesia pump (containing a mixture of 0.08% ropivacaine and 0.4 ug/ml sufentanil) will be connected to the epidural catheter and programmed to deliver a 6-ml bolus with a 20-minute lockout interval and a 4 ml/h background infusion. Analgesia will be terminated at the end of the third stage of labor.

干预措施: Individualized epidural analgesia (Drug)

Routine epidural analgesia

Active Comparator

Epidural catheterization will be performed after the beginning of the first stage of labor and the cervix is dilated to 1 cm or more. Epidural analgesia will then begin. A loading dose (10 ml mixture of 0.1% ropivacaine and 0.5 ug/ml sufentanil) will be administered through the epidural catheter. After a 20-minute period observation, a patient-controlled analgesia pump (containing a mixture of 0.08% ropivacaine and 0.4 ug/ml sufentanil) will be connected to the epidural catheter and programmed to deliver a 6-ml bolus with a 20-minute lockout interval and a 4 ml/h background infusion. Analgesia will be terminated at the end of the third stage of labor.

干预措施: Routine epidural analgesia (Drug)

结局指标

主要结局

The most severe labor pain score during labor

时间窗: Assessed at 24 hours after delivery

Assessed with numeric rating scale, where 0 indicates no pain and 10 the worst pain.

次要结局

  • Incidence of instrumental delivery(At the time of delivery)
  • Neonatal Apgar score(At 1 and 5 minutes after delivery)
  • Maternal satisfaction with labor analgesia(Assessed at 24 hours after delivery)
  • Persistent pain score at 24 hours and 42 days after delivery(At 24 hours and 42 days after delivery)
  • Rate of breast-feeding(At 24 hours and 42 days after delivery)
  • Incidence of Cesarean delivery(At the time of delivery)
  • Incidence of postpartum depression(At 42 days after delivery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dong-Xin Wang

Professor and Chairman, Department of Anesthesiology and Critical Care Medicine

Peking University First Hospital

研究点 (1)

Loading locations...

相似试验